ArticleThe international journal of neuropsychopharmacology2022

Selective Orexin Receptor Antagonists as Novel Augmentation Treatments for Major Depressive Disorder: Evidence for Safety and Efficacy From a Phase 2B Study of Seltorexant.

Manish Kumar JhaPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.